Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 [1]

Nature Immunology

Volumn 3, Issue 6, 2002, Pages 499-

  Jurk, Marion ^a   Heil, Florian ^b   Vollmer, Jörg ^a   Schetter, Christian ^a   Krieg, Arthur M ^a   Wagner, Hermann ^b   Lipford, Grayson ^a   Bauer, Stefan ^b  

^a PFIZER INC   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; RESIQUIMOD; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG;

CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; HUMAN; IMMUNOSTIMULATION; LETTER; MACROPHAGE; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DROSOPHILA PROTEINS; HUMANS; IMIDAZOLES; MEMBRANE GLYCOPROTEINS; MICE; NF-KAPPA B; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8; TOLL-LIKE RECEPTORS; TRANSFECTION;

EID: 0036088492     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni0602-499     Document Type: Letter

References (10)